Desferal - 0078-0467-91 - (deferoxamine mesylate)

Alphabetical Index


Drug Information of Desferal

Product NDC: 0078-0467
Proprietary Name: Desferal
Non Proprietary Name: deferoxamine mesylate
Active Ingredient(s): 500    mg/1 & nbsp;   deferoxamine mesylate
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Desferal

Product NDC: 0078-0467
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA016267
Marketing Category: NDA
Start Marketing Date: 19680402

Package Information of Desferal

Package NDC: 0078-0467-91
Package Description: 4 VIAL in 1 CARTON (0078-0467-91) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61)

NDC Information of Desferal

NDC Code 0078-0467-91
Proprietary Name Desferal
Package Description 4 VIAL in 1 CARTON (0078-0467-91) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61)
Product NDC 0078-0467
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name deferoxamine mesylate
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 19680402
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name DEFEROXAMINE MESYLATE
Strength Number 500
Strength Unit mg/1
Pharmaceutical Classes Iron Chelating Activity [MoA],Iron Chelator [EPC]

Complete Information of Desferal


General Information